1,3- -D-Glucan Antigenemia for Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute Leukemia
Open Access
- 15 March 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (6), 878-885
- https://doi.org/10.1086/527382
Abstract
Background. Invasive fungal infections (IFIs) are life-threatening complications in neutropenic patients with hematological malignancies. Because early diagnosis of IFI is difficult, new noninvasive, culture-independent diagnostic tools are needed to improve clinical management. Recent studies have reported that detection of 1,3-β-d-glucan (BG) antigenemia may be useful for diagnosis of IFI. The aim of the present prospective study was to evaluate the usefulness of monitoring BG in patients undergoing chemotherapy for acute leukemia. Methods. BG antigenemia was measured by a colorimetric assay twice weekly in the absence of fever and daily in the presence of fever. IFIs were classified according to the criteria of the European Organization for Research and Treatment of Cancer/Mycoses Study Group. Results. During 190 consecutive neutropenic episodes (median duration, 22 days; range, 7–113 days) in 95 patients, 30 proven or probable IFIs (13 aspergillosis, 15 candidiasis, and 2 mixed IFIs) were diagnosed. Sensitivity, specificity, positive predictive value, negative predictive value, and efficiency of 2 consecutive BG values ⩾7 pg/mL for diagnosis of proven or probable IFI was 0.63 (95% confidence interval, 0.44–0.79), 0.96 (95% confidence interval, 0.89–0.98), 0.79 (95% confidence interval, 0.57–0.92), 0.91 (95% confidence interval, 0.84–0.95), and 0.89, respectively. The time interval between onset of fever as first sign of IFI and BG antigenemia was significantly shorter than the time to diagnosis of IFI by clinical, microbiological, radiological, and/or histopathological criteria (P<.001). BG values >50 pg/mL were observed in only 2 patients, both of whom experienced failure of antifungal therapy. Conclusion. Monitoring of BG antigenemia is a useful noninvasive method for early diagnosis of IFI in patients with acute leukemia.Keywords
This publication has 38 references indexed in Scilit:
- Prevention and Early Treatment of Invasive Fungal Infection in Patients with Cancer and Neutropenia and in Stem Cell Transplant Recipients in the Era of Newer Broad-Spectrum Antifungal Agents and Diagnostic AdjunctsClinical Infectious Diseases, 2007
- Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host DiseaseNew England Journal of Medicine, 2007
- Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with NeutropeniaNew England Journal of Medicine, 2007
- Prophylaxis and Aspergillosis — Has the Principle Been Proven?New England Journal of Medicine, 2007
- Reactivity of (1→3)-β- d -Glucan Assay with Commonly Used Intravenous AntimicrobialsAntimicrobial Agents and Chemotherapy, 2006
- Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional StudyClinical Infectious Diseases, 2006
- Between over- and undertreatment of invasive fungal disease.Clinical Infectious Diseases, 2005
- Should the Consensus Guidelines' Specific Criteria for the Diagnosis of Invasive Fungal Infection Be Changed?Clinical Infectious Diseases, 2005
- Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodiesDiagnostic Microbiology and Infectious Disease, 2005
- Influence of various hemodialysis membranes on the plasma (1→3)-β-D-glucan levelKidney International, 2001